Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,751.5
44.3 (1.64%)

 

  • STI Straits Times Index
    2,751.5
    44.3 (1.64%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,556.3
    -5.5 (-0.35%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,770.4
    404.1 (1.66%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,930.8
    11.5 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,863.7
    168.0 (0.74%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,947.8
    31.1 (0.63%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,257.5M
  • Value: 1,627.4M
  • Rise: 285
  • Fall: 84
  • Unch: 440

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.191+0.004
Singtel2.630+0.050
ComfortDelGro1.620+0.050
MDR0.001-
SIA4.330-0.050
Synagie0.129+0.001
Genting Sing0.830+0.010
Parkson Retail^0.018+0.006
ThaiBev0.725+0.020
SPH1.360-0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,814.1 +198.3
HSI 24,770.4 +404.1
HSCEI 10,066.2 +98.3
Jakarta 4,947.8 +31.1
Nikkei 225 22,863.7 +168.0
SSE Comp 2,930.8 +11.6
Shanghai A 3,072.0 +12.1
Shanghai B 208.1 +2.5
KOSPI 2,181.9 +30.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MYRIAD GENETICS INC MYRIAD GENETICS
Updated on 04 Jun 2020 (End of trading day)
Last (USD): 15.920 Change: +0.420 High: 16.200 Remarks: -
Change (%): +2.71 Low: 15.260
Open 15.470 Yesterday's Close 15.5
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,923,553 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.06170 Trailing EPS (USD) e -1.98914 NAV (USD) b 12.9730
PE a 258.023 Trailing PE f - Price / NAV b 1.2272
Dividend (USD) d - Cash In Hand (USD) g 1.6230 Issued & Paid-up Shares c 74,554,700
Dividend Yield (%) d - Price / Cash In Hand g 9.809 Treasury Shares h -
Market Cap (M) 1,186.911 Enterprise Value (M) 1,299.411
Piotroski F Score 4 Exchange Code MYGN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 102.86 Free Float (%) 97.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MYRIAD GENETICS INC NASDAQ 1,186.911 258.023 - 1.2272 -
Industry Biotechnology NASDAQ 2,763.412 347.452 5136.815 6.7182 0.698
Local Peer AMGEN INC NASDAQ 129,931.997 16.569 16.929 13.6987 2.640
Local Peer GILEAD SCIENCES INC NASDAQ 97,235.160 18.053 19.596 4.4064 3.281
Local Peer VERTEX PHARMACEUTICAL NASDAQ 70,735.951 60.108 46.816 10.9470 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 67,348.900 31.831 29.548 5.5509 -
Local Peer ILLUMINA INC NASDAQ 52,684.800 52.580 55.929 11.3667 -
Local Peer BIOGEN INC NASDAQ 48,898.985 8.304 8.318 3.8973 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,039.734 - - 14.7482 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,103.613 10.441 10.574 2.1369 -
Local Peer MODERNA INC NASDAQ 22,492.462 - - 13.7075 -
Local Peer INCYTE CORPORATION NASDAQ 20,389.587 45.624 - 10.5224 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 19,441.786 - 170.533 6.0006 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 14,914.197 - - 11.0498 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALKERMES PLC (NASDAQ), UNIQURE N.V. (NASDAQ), NOVAVAX INC (NASDAQ), INSMED INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), XENCOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), COMPUGEN (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), OMEROS CORP (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), NEXTCURE INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ARDELYX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), PRECIGEN INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), VBI VACCINES INC CDA (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MERUS B V (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), SERES THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VERMILLION INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), VERASTEM INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), AFFIMED N V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), XOMA CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MEDICINOVA INC (NASDAQ), INFLARX N V (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), ARAVIVE INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMV INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ORGENESIS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TREVENA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SAVARA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VACCINEX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), INMUNE BIO INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), CURIS INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOCARDIA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), OCUGEN INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 129,553.801 48.288 44.723 14.9801 0.930
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 28,141.936 26.276 41.203 5.9022 0.720
Global Peer SINO BIOPHARM HKEx 171,575.539 55.900 56.413 4.9521 0.584
Global Peer WUXI BIO HKEx 168,963.017 146.980 146.979 11.8152 -
Global Peer BEIGENE HKEx 105,211.582 - - 4.8268 -
Global Peer GENSCRIPT BIO HKEx 36,379.044 - - 12.1967 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,446.926 81.595 65.300 4.1374 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer 3SBIO HKEx 26,146.550 23.681 23.681 2.4285 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), DPHARMA (Bursa), TELIX PHARMACEUTIC (ASX), BBI LIFE SCI (HKEx), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), IBIO INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), IMUGENE LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ORAGENICS INC (NYSE American), CONSTELLATION TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), BIONOMICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), Suntar Eco-City (SGX), PRESCIENT THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), CRYOSITE (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.390
+9.57 %
10 Days -+1.190
+8.08 %
20 Days -+1.300
+8.89 %
Medium Term Return 3 Months --0.450
-2.75 %
6 Months --9.690
-37.84 %
1 Year --9.090
-36.35 %
Long Term Return 2 Years --23.250
-59.36 %
3 Years --6.060
-27.57 %
5 Years --16.050
-50.20 %
Annualised Return Annualised --
-13.02 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 9.240 - 48.400 Change From 1 Year Low +6.680 % Change From 1 Year Low (%) +72.29
Change From 1 Year High -32.480 % Change From 1 Year High (%) -67.11
2 Years Range 9.240 - 50.440 Change From 2 Years Low +6.680 % Change From 2 Years Low (%) +72.29
Change From 2 Years High -34.520 % Change From 2 Years High (%) -68.44
5 Years Range 9.240 - 50.440 Change From 5 Years Low +6.680 % Change From 5 Years Low (%) +72.29
Change From 5 Years High -34.520 % Change From 5 Years High (%) -68.44
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Jun 2020 15.470 16.200 15.260 15.920 1,923,553 -
03 Jun 2020 15.500 15.800 15.380 15.500 1,389,323 -
02 Jun 2020 15.190 15.840 15.000 15.390 1,959,448 -
01 Jun 2020 14.650 15.630 14.500 15.190 1,661,292 -
29 May 2020 14.360 14.620 14.170 14.530 1,163,070 -
28 May 2020 14.680 14.830 14.340 14.410 917,727 -
27 May 2020 14.410 14.790 13.750 14.590 1,365,447 -
26 May 2020 15.000 15.200 14.140 14.265 1,087,689 -
22 May 2020 14.720 14.810 14.090 14.730 553,365 -
21 May 2020 14.590 15.040 14.530 14.690 538,622 -
20 May 2020 14.824 15.180 14.467 14.610 865,976 -
19 May 2020 14.970 15.090 14.480 14.490 620,592 -
18 May 2020 15.410 15.550 14.790 15.000 821,495 -
15 May 2020 14.210 14.880 14.171 14.730 857,691 -
14 May 2020 14.700 14.850 13.840 14.280 815,186 -
13 May 2020 14.270 15.000 14.000 14.980 1,044,745 -
12 May 2020 16.110 16.130 14.270 14.370 1,135,968 -
11 May 2020 15.230 16.060 14.895 15.920 2,250,847 -
08 May 2020 15.160 15.160 13.940 14.620 1,274,470 -
07 May 2020 14.410 15.240 14.270 14.910 1,179,877 -
06 May 2020 13.510 14.632 13.280 14.230 1,472,754 -
05 May 2020 15.670 15.820 14.410 14.820 1,780,926 -
Summary
Current 2 Weeks
(21 May 2020 to 04 Jun 2020)
14.590 16.200 13.750 15.920 12,559,536 -
Previous 2 Weeks
(07 May 2020 to 20 May 2020)
14.410 16.200 13.750 14.610 10,866,847 -
4 Weeks from
(08 Apr 2020 to 06 May 2020)
14.960 16.200 13.410 14.230 18,757,501 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.